Event
R&D and entrepreneurship
AI helps create a drug that reduced patients' biological age by six years
5 sourcesPublished · Updated
The experimental drug Rentosertib, developed by Insilico Medicine using artificial intelligence, showed a reduction in biological age by six years in 42 patients. The study revealed changes in six aging markers, although the results do not confirm actual rejuvenation or the drug's ability to extend life.
Key facts
- Drug Rentosertib
- Biological age reduced by 6 years
- 42 patients participated in the study
- Developed by Insilico Medicine
- Testing on patients with lung diseases
Insilico Medicine · Rentosertib · patients · researchers
Sources5
Compare newsrooms
Reports from one newsroom's different channels are grouped together. Different newsrooms can share owners; their count does not establish independent corroboration. How we identify sources and blocs
Discussion
Comments